Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties. - Wikidata - wikimedia - TriplyDB

Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties.

Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties.

http://www.wikidata.org/entity/Q33857229

about

Influence of light on aryl hydrocarbon receptor signaling and consequences in drug metabolism, physiology and disease Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor Comparisons of differential gene expression elicited by TCDD, PCB126, βNF, or ICZ in mouse hepatoma Hepa1c1c7 cells and C57BL/6 mouse liver.Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines.The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis Ah receptor antagonism inhibits constitutive and cytokine inducible IL6 production in head and neck tumor cell lines.Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3',4'-dimethoxy-α-naphthoflavone Aryl hydrocarbon receptor-dependent retention of nuclear HuR suppresses cigarette smoke-induced cyclooxygenase-2 expression independent of DNA-binding.Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism.Aryl hydrocarbon receptor ligands in cancer: friend and foe.Genetic and pharmacological analysis identifies a physiological role for the AHR in epidermal differentiation.Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.Differential regulation of Th17 and T regulatory cell differentiation by aryl hydrocarbon receptor dependent xenobiotic response element dependent and independent pathways Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent manner Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation.Selective aryl hydrocarbon receptor modulator-mediated repression of CD55 expression induced by cytokine exposure Aryl Hydrocarbon Receptor Activation Synergistically Induces Lipopolysaccharide-Mediated Expression of Proinflammatory Chemokine (c-c motif) Ligand 20.Lack of ligand-selective binding of the aryl hydrocarbon receptor to putative DNA binding sites regulating expression of Bax and paraoxonase 1 genes.Ligand promiscuity of aryl hydrocarbon receptor agonists and antagonists revealed by site-directed mutagenesis.Ah receptor antagonism represses head and neck tumor cell aggressive phenotype.A role of the aryl hydrocarbon receptor in attenuation of colitis.Atranorin and lecanoric acid antagonize TCDD-induced xenobiotic response element-driven activity, but not xenobiotic response element-independent activity.Editor's Highlight: Ah Receptor Activation Potentiates Neutrophil Chemoattractant (C-X-C Motif) Ligand 5 Expression in Keratinocytes and Skin.High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.Ligand-mediated cytoplasmic retention of the Ah receptor inhibits macrophage-mediated acute inflammatory responses.Synthesis of 1H-indazoles from N-tosylhydrazones and nitroaromatic compounds.

P2860

Q23919671-1218993B-C062-493D-B4D9-EB2CF65BD8F0 Q28392826-9BF4EB61-76B4-4E39-B61F-D8989248D277 Q33896948-B3CEDAAA-2B9B-4266-BB5E-463BF2A14FCE Q34123737-4FD07699-EB87-4134-B72A-C257D4C77EF0 Q34485137-F1C83AFF-3272-4409-B02A-0DBA13EC234D Q34605176-979475D8-6824-4FAC-87A2-A321920C0C85 Q34625038-8FC620C1-D0CC-46C2-8DCF-29323916D863 Q34680466-428BAF7E-A9F8-43CD-A183-9E66439A7329 Q34701028-C9F6C546-DCAD-4C48-B4B1-3C98A400C9A4 Q35005262-A8B1A824-6477-4A77-8FB6-BC79DBE4F25C Q35077899-2E5683EF-2B12-4AB0-9F8A-E733A9B00D9E Q35458027-BBF1C987-1D9B-4E8A-ACD9-EAB4EBA067C7 Q35470109-107183C6-CE65-49D6-8482-39B86A9E7D13 Q35667189-497307C9-7E39-467A-B286-3ED936DDAB6D Q35753510-FF9B9C61-0824-431F-BF01-0EFDD24CCFB6 Q35923118-913AAF6D-BA5A-4C4B-A06F-1035DD0DA5EC Q36077694-E92406CA-8DD7-4956-AF11-F88F78254E16 Q36105385-6B500AA4-8F1C-430F-9F69-C72257EFC848 Q36515917-4B6EC271-C57C-4E83-9B82-4D3609898EB6 Q37419695-25264B93-05DC-4C7F-A3A2-33055C9B3719 Q37713643-B8D5717D-2D27-4144-A53F-FE56F4D6F6EB Q39293280-485F3843-904E-4A00-B86F-353B883BCED0 Q39581558-A3AC2BA8-3BF9-48E9-9E28-44779009BEC3 Q40852561-1E71803C-5D0C-4108-A43A-CF2166B8DA71 Q42516174-9B88541C-6E13-4F1C-AE06-187A2B863B11 Q47213795-647B90B9-7264-4391-85D7-BAA934AEFA08 Q47322580-18BD9D72-4A46-4323-9C8A-B60419C576E8 Q47823494-56154113-AE43-4171-A390-E81D05028BE9 Q53579102-5B885F22-8CA6-43A4-B303-80BE00FDA6DE

P2860

Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties.

http://www.wikidata.org/entity/Q33857229

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Development of a selective mod ...... anti-inflammatory properties.

@ast

Development of a selective mod ...... anti-inflammatory properties.

@en

type

label

Development of a selective mod ...... anti-inflammatory properties.

@ast

Development of a selective mod ...... anti-inflammatory properties.

@en

prefLabel

Development of a selective mod ...... anti-inflammatory properties.

@ast

Development of a selective mod ...... anti-inflammatory properties.

@en

P1433

Q33857229-8F261B0C-12F7-4C6D-BD44-8F62981A8B70

P1476

Q33857229-25AE449E-BE9B-42E7-9B2E-0ED91BF04D33

P2093

Q33857229-03D8DB9C-76AE-4FD1-8DD6-1B82E494F077

Q33857229-300A37E3-7B01-4760-BC0A-8DC9ED26EF3F

Q33857229-421D8D51-5D0E-4504-9A79-3033191F0397

Q33857229-45E67F63-A4D2-44CA-90AE-F302D6F0771E

Q33857229-68C3FE61-E7FB-421A-98D4-70461F0525F0

Q33857229-A93E9846-DA70-4E5B-AFC4-42C8F056B81B

Q33857229-B9524459-416A-41B8-A72F-19197E4EEE00

Q33857229-DFFF08FC-656B-4E0B-AE01-A5DAA1AA2F09

Q33857229-E0EE2409-0849-42F7-BBE8-3580B63042A7

P2860

Q33857229-009C6643-8064-4EE8-864D-D35AC414265F

Q33857229-087F8455-B8B7-438D-BFA6-4200BFABFCD8

Q33857229-0986DFE3-4239-45FA-9B5D-EB72EB74EE9D

Q33857229-0D703F68-087E-462A-A9BB-D0634C168059

Q33857229-11F699D0-506A-4B04-BF0D-9299583E39C3

Q33857229-186C35E3-764B-4026-897F-F19E3188B676

Q33857229-18F2A079-EA5F-44C5-B3C8-6F2139247737

Q33857229-211919F8-B2F2-4F48-BFD5-20E492B7E80D

Q33857229-3051DDD0-8938-4085-B7AD-CFECA0D29D32

Q33857229-31A5B75B-23EE-46F7-8E7B-4CBE7F127C33

P304

Q33857229-68740745-2D89-4500-B6CE-9148DF415FE8

P31

Q33857229-453D468D-58CC-426B-9ECA-7F4B9E2F4240

P356

Q33857229-ECA02EE5-AC64-4B49-BD0F-C4A146583591

P433

Q33857229-B638F29E-1DFD-418F-B850-71E774C4D10C

P478

Q33857229-D6D5BA8A-1934-4B86-845F-DFF1FE7BA35C

P577

Q33857229-BDA16F04-9368-4A51-801C-B51BB3404548

P5875

Q33857229-8FBC4BC5-BAAC-4B08-9051-318AF1AF397A

P698

Q33857229-AC11B2A5-A8B0-4950-93A7-63115EAE4F7E

P932

Q33857229-34B4DE53-971F-46FE-88B1-163065D94175

P356

P1433

Chemical Research in Toxicology

P1476

Development of a selective mod ...... anti-inflammatory properties.

@en

P2093

Arun K Sharma

http://www.w3.org/2001/XMLSchema#string

Brett C DiNatale

http://www.w3.org/2001/XMLSchema#string

Chris Chiaro

http://www.w3.org/2001/XMLSchema#string

Colin Flaveny

http://www.w3.org/2001/XMLSchema#string

Gary H Perdew

http://www.w3.org/2001/XMLSchema#string

Gowdahalli Krishnegowda

http://www.w3.org/2001/XMLSchema#string

Iain A Murray

http://www.w3.org/2001/XMLSchema#string

Jyh-Ming Lin

http://www.w3.org/2001/XMLSchema#string

Shantu Amin

http://www.w3.org/2001/XMLSchema#string

P2860

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study

The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-kappa B transcriptional activity in models of rheumatoid arthritis

Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context

Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A

Acute-phase proteins and other systemic responses to inflammation

The aryl hydrocarbon receptor complex and the control of gene expression

The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins

Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity.

P304

955-966

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/TX100045H

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43347340

http://www.w3.org/2001/XMLSchema#string

P698

20423157

http://www.w3.org/2001/XMLSchema#string

P932

2871980

http://www.w3.org/2001/XMLSchema#string